The slip
PARKINSON RECEIPTno. 11220
26 Oct 2026, 21:24 UTCdopamine neurons, braak
predictionLRRC8D in dopamine neurons tracks Braak Lewy-body stage
registered10221283b97b92b3
discovery+0.55 p=0.125 n=9
replication+0.14 p=0.714 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.55, p 0.125)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT95380694f66c7fda1e75e839…
follows 324bb43eb9f6…
Covered by the on-chain checkpoint of receipt 11237 (2026-10-26 21:49 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11220: LRRC8D in dopamine neurons, braak
- power
- full sample +0.33 (p 0.176, n 18), 95% CI -0.16 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.38 (p 0.123, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.41 (p 0.095, n 18). could be the mix.
- skeptic
- leave-one-out range +0.24 to +0.50, sign flips 0; without severely affected donors +0.33 (p 0.176, n 18). fragile.
- cell type
- strongest in astrocytes: +0.63 (p 0.0051, n 18) vs +0.33 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRRC8D in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up LRRC8D · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.03 p 0.929 (needs p < 1.9e-4)